Researchers have been excited about the medication , a innovative dual agonist showing promising results in clinical trials for weight reduction . It functions by targeting several pathways : GLP-1 and GIP, these, when engaged , assist regulate cravings and enhance metabolism . Early findings demonstrate substantial weight management and likely imp